Four IRIC researchers obtain funding from the Canadian Institutes of Health Research
Published on July 19, 2022
Resulting from the most recent research grant competition of the Canadian Institutes of Health Research (CIHR), four IRIC researchers obtained funds via the Project grant program. This program aims to support original ideas having the potential to advance basic and applied health-related knowledge.
Representing a total investment of $325 million, 405 applications were funded across the country, including three from IRIC:
- Michel Bouvier, director of the Molecular Pharmacology Research Unit and Chief Executive Officer of IRIC, obtains a grant of $1,063,350 over five years for the project “Mechanisms and consequences of spatially controlled G protein-coupled receptor signaling”.
- Jean-Claude Labbé, director of the Cell Division and Differentiation Research Unit, and Matthew Smith, director of the Cancer Signalling and Structural Biology Research Unit, receive an $833,850 grant for a period of five years for the project “Regulation of cytokinesis by the novel and conserved flavin-dependent monooxygenase enzymes OSGN -1/OSGIN”.
- Sylvain Meloche, director of the Cell Signaling and Growth Research Unit, obtains a grant of $956,250 over five years for the project “Development and preclinical validation of first-in-class dual inhibitors of the atypical MAP kinases ERK3 and ERK4”.
Congratulations to these teams!